Related Experiment Video
Updated: Jan 28, 2026

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
Published on: December 30, 2016
A Regulatory Circuit Controlling the Dynamics of NFκB cRel Transitions B Cells from Proliferation to Plasma Cell
Koushik Roy1, Simon Mitchell1, Yi Liu1
1Signaling Systems Laboratory, Institute for Quantitative and Computational Biosciences and Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Insights
The transcription factor NFκB cRel dynamically regulates B cell differentiation into antibody-secreting cells (ASCs). This study reveals how Blimp1-mediated repression of cRel controls B cell proliferation and ASC generation, offering insights into immune disorders.
Area of Science:
- Immunology
- Computational Biology
- Molecular Biology
Background:
- Humoral immunity relies on B cell activation and differentiation into antibody-secreting cells (ASCs).
- The transcription factor NFκB cRel is crucial for B cell proliferation.
- Previous models struggled to incorporate cRel's regulatory roles in ASC differentiation.
Purpose of the Study:
- To investigate the role of NFκB cRel in B cell differentiation into ASCs.
- To develop a mathematical model explaining the dynamic regulation of ASC generation.
- To elucidate the mechanism by which cRel influences B cell population dynamics.
Main Methods:
- Mathematical modeling of the B cell differentiation circuit.
- Incorporation of cRel and Blimp1 regulatory interactions.
- Simulations of B cell proliferation and ASC generation phases.
- Analysis of bi-stable circuit dynamics and mutual antagonism between cRel and Blimp1.
Main Results:
- Ectopic cRel expression inhibited ASC differentiation by blocking the transcription factor Blimp1.
- In wild-type cells, Blimp1 dynamically repressed cRel during ASC differentiation.
- A multi-scale model incorporating mutual cRel-Blimp1 antagonism revealed dynamic cRel repression controls the switch between B cell proliferation and ASC generation.
- This dynamic repression governs cell population dynamics during humoral immune responses.
Conclusions:
- Dynamic repression of NFκB cRel by Blimp1 is essential for timely ASC generation.
- Dysregulation of the cRel-Blimp1 bi-stable circuit can lead to pathologic B cell phenotypes.
- These findings offer potential diagnostic and therapeutic strategies for immune-related diseases.
Abstract:
Humoral immunity depends on efficient activation of B cells and their subsequent differentiation into antibody-secreting cells (ASCs). The transcription factor NFκB cRel is critical for B cell proliferation, but incorporating its known regulatory interactions into a mathematical model of the ASC differentiation circuit prevented ASC generation in simulations. Indeed, experimental ectopic cRel expression blocked ASC differentiation by inhibiting the transcription factor Blimp1, and in wild-type (WT) cells cRel was dynamically repressed during ASC differentiation by Blimp1 binding the Rel locus. Including this bi-stable circuit of mutual cRel-Blimp1 antagonism into a multi-scale model revealed that dynamic repression of cRel controls the switch from B cell proliferation to ASC generation phases and hence the respective cell population dynamics. Our studies provide a mechanistic explanation of how dysregulation of this bi-stable circuit might result in pathologic B cell population phenotypes and thus offer new avenues for diagnostic stratification and treatment.
Related Concept Videos
Cells Coordinate Growth and Proliferation
Phase Transitions
Cis-regulatory Sequences
Drug Control Governance: Regulatory Bodies and Their Impact
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System

